Q: Can you provide an updated opinion and stock price target for MDA.
5i Research Answer:
We did have some MDA comments posted yesterday. The outlook remains quite good in our view, both fundamentally and while sector sentiment improves dramatically. The stock is not cheap at 31X earnings but compares well to peers. The balance sheet is very strong and good EPS growth is expected through 2029. The recent contract adds substantial growth visibility. Analysts have a target of $53 and we see that as quite doable.